Your Representative is on the Committee Discussing this Issue

Take Action!

Providing the Food and Drug Administration (FDA) with a statutory pathway for approving safe, effective, and lower-cost versions of biotech drugs can help improve the lives of people with multiple sclerosis (MS) and other diseases. As Congress works toward re-authorizing the Prescription Drug User Fee Act (PDUFA), it makes sense to attach FDA-related legislation that would also advance generic versions of biotech drugs.

Write your Representative today and ask them to support bio-generic drugs by including the Access to Life-Saving Medicine Act (H.R. 1038) with the re-authorization of PDUFA. Click above to take action.

Many people living with MS depend on biologic drugs to sustain or improve their quality of life. But the cost of biologic drugs ($16,500 to $26,000 each year) can force many to stop their prescribed therapies because they cannot afford them. Currently, no generic alternatives are available for this fast-growing and expensive category of drugs.

The Access to Life-Saving Medicine Act — introduced by Congressman Waxman — would provide a statutory pathway for the FDA to review and approve safe, effective, and affordable generic biological therapies. Please write your Representative and ask them to attach the Access to Life-Saving Medicine Act with PDUFA. Thank you.

We are MS Activists
Join the Movement at www.nationalMSsociety.org/advocacy

To keep future MS activism messages out of your junk folder, add the following address to your contacts or safe sender list: MSActionNetwork@nmss.org